Department of Oncology, St. Jude Children's Hospital Memphis, Memphis, Tennessee, USA.
Department of Pediatrics, UT Southwestern Medical Center Dallas, Dallas, Texas, USA.
Pediatr Blood Cancer. 2023 Jul;70(7):e30361. doi: 10.1002/pbc.30361. Epub 2023 Apr 19.
In this retrospective study, we examined the prevalence and spectrum of germline variants in selected cancer predisposition genes in 38 children and young adults with melanocytic lesions at St. Jude Children's Research Hospital. Diagnoses included malignant melanoma (n = 16; 42%), spitzoid melanoma (n = 16; 42%), uveal melanoma (n = 5; 13%), and malignant melanoma arising in a giant congenital melanocytic nevus (n = 1; 3%). Six patients (15.8%) harbored pathogenic germline variants: one with bi-allelic PMS2 variants, one with a heterozygous 17q21.31 deletion, and one each with a pathogenic variant in TP53, BRIP1, ATM, or AXIN2. Overall, 15.8% of patients harbored a cancer-predisposing genetic variant.
在这项回顾性研究中,我们在圣裘德儿童研究医院检查了 38 名患有黑色素细胞病变的儿童和年轻患者中选定的癌症易感性基因的种系变异的流行率和谱。诊断包括恶性黑色素瘤(n=16;42%)、Spitz 样黑色素瘤(n=16;42%)、葡萄膜黑色素瘤(n=5;13%)和源于巨大先天性黑色素细胞痣的恶性黑色素瘤(n=1;3%)。6 名患者(15.8%)携带致病性种系变异:一名患者存在双等位基因 PMS2 变异,一名患者存在杂合性 17q21.31 缺失,一名患者分别存在 TP53、BRIP1、ATM 或 AXIN2 中的致病性变异。总体而言,15.8%的患者携带了一种易患癌症的遗传变异。